Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases - Chantasrisawad, Napaporn; Puthanakit, Thanyawee; Tangsathapornpong, Auchara; Techasaensiri, Chonnamet; Phongsamart, Wanatpreeya; Suwanpakdee, Detchvijitr; Jaruampornpan, Peera; Sophonphan, Jiratchaya; Suntarattiwong, Piyarat; Chotpitayasunondh, Tawee (Vaccines (Basel), 2022)
Keywords: adolescent; Adolescents; BNT162b2; Cancer; Chronic illnesses; Coronaviruses; COVID-19; COVID-19 vaccines; HIV; Human immunodeficiency virus; Immune response; Immune system; Immunity; immunocompromised; Immunogenicity; Immunoglobulin G; Immunosuppressive agents; mRNA; Multisystem inflammatory syndrome in children; Neutralization; SARS-CoV-2 antibody; Transplantation; Viral diseases; Thailand; United States--US; Bangkok Thailand; adolescent; BNT162b2; immunocompromised; SARS-CoV-2 antibody